|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 544.86 USD | -3.58% |
|
+4.15% | -1.79% |
| 06-17 | Medpace: At the Heart of the Small-Cap Biopharma Crisis |  |
| 06-05 | PriorNilsson Evolve Global rose 3.64 percent in May - trimmed positions in Beijer Alma and OEM | FW |
| Market Cap | 16.14B 14.13B 13.02B 12.08B 22.95B 1,539B 23.26B 156B 60.65B 756B 60.61B 59.28B 2,620B | P/E 2026 * |
33.3x | P/E 2027 * | 30.5x |
|---|---|---|---|---|---|
| Enterprise Value | 14.97B 13.11B 12.08B 11.21B 21.29B 1,428B 21.57B 145B 56.26B 701B 56.22B 54.98B 2,430B | EV / Sales 2026 * |
5.4x | EV / Sales 2027 * | 4.93x |
| Free-Float |
80.38% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Medpace Holdings, Inc.
| 1 day | -3.94% | ||
| 1 week | +4.15% | ||
| Current month | +4.15% | ||
| 1 month | +20.46% | ||
| 3 months | +8.47% | ||
| 6 months | -10.03% | ||
| Current year | -1.79% |
| 1 week | 530.98 |  | 567.91 |
| 1 month | 445 | | 567.91 |
| Current year | 373 | | 628.92 |
| 1 year | 306.7 | | 628.92 |
| 3 years | 227.21 | | 628.92 |
| 5 years | 126.94 | | 628.92 |
| 10 years | 21.76 | | 628.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
August Troendle
CEO | Chief Executive Officer | 69 | 1992-06-30 |
Kevin Brady
DFI | Director of Finance/CFO | 51 | 2021-07-31 |
Reinilde Heyrman
CTO | Chief Tech/Sci/R&D Officer | 65 | 2017-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
August Troendle
CHM | Chairman | 69 | 1992-06-30 |
Robert Kraft
BRD | Director/Board Member | 55 | 2016-06-30 |
Brian Carley
BRD | Director/Board Member | 72 | 2016-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-29 | Fiscal year | Director | 56 | 0.0002% | ||
| 06-29 | Fiscal year | Director | 72 | 0.0003% | ||
| 06-29 | Fiscal year | Director | 66 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.58% | +4.15% | +72.96% | +134.19% | 16.14B | |
| +0.07% | +6.30% | +3.98% | +10.51% | 50.25B | |
| -0.99% | +1.16% | +416.63% | +617.89% | 40.39B | |
| -0.16% | +7.99% | +28.44% | -3.76% | 34.38B | |
| -0.88% | +6.85% | +26.35% | +60.64% | 34.4B | |
| -4.19% | -1.84% | +3.76% | +32.17% | 26.32B | |
| +0.33% | +1.17% | - | - | 16.64B | |
| +1.46% | +1.66% | +15.63% | +22.84% | 13.71B | |
| +0.60% | +5.33% | +99.89% | +99.89% | 13.75B | |
| -3.03% | +7.53% | +1,726.47% | +681.13% | 12.69B | |
| Average | -1.18% | +8.68% | +266.01% | +183.94% | 25.87B | |
| Weighted average by Cap. | -1.08% | +6.52% | +180.48% | +168.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.77B 2.43B 2.24B 2.08B 3.94B 265B 4B 26.79B 10.43B 130B 10.42B 10.19B 450B | 2.95B 2.58B 2.38B 2.21B 4.19B 281B 4.25B 28.46B 11.07B 138B 11.07B 10.82B 478B |
| Net income | 493M 431M 397M 369M 701M 47B 710M 4.76B 1.85B 23.07B 1.85B 1.81B 79.98B | 540M 473M 436M 404M 768M 51.51B 778M 5.21B 2.03B 25.28B 2.03B 1.98B 87.66B |
| Net Debt | -1.17B -1.02B -943M -875M -1.66B -112B -1.68B -11.29B -4.39B -54.73B -4.39B -4.29B -190B | -1.62B -1.42B -1.31B -1.21B -2.3B -154B -2.33B -15.62B -6.08B -75.75B -6.08B -5.94B -263B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-07 | US$551.59 | -2.39% | 13,720 |
| 26-07-06 | US$565.09 | +1.34% | 234,162 |
| 26-07-02 | US$557.60 | +2.58% | 356,575 |
| 26-07-01 | US$543.57 | +2.64% | 312,635 |
| 26-06-30 | US$529.59 | -0.96% | 335,554 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MEDP Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
